The embargo on all abstracts part of the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium will lift at 5:00 p.m. ET on Monday, January 22, 2018. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 22 for credentialed media.
Attend the Meeting in Person/Participate in the Presscast
Media registration for the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium will open in mid-November. At that time, you can visit ASCO's Media Headquarters to apply for media credentials,* register to attend an upcoming meeting, and access embargoed meeting information. For questions about how to navigate the site, please contact ASCO Media Registration.
Access Embargoed Information
Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.
Meet the News Planning Team
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Response to Cancer Immunotherapy May Depend on Gut Bacteria
ALEXANDRIA, Va. – Researchers have found a link between microbes in the gut (the microbiome) and response to immunotherapy. Read the full release.
Utility of Biomarkers for Predicting Colorectal Cancer Survival Depends on Tumor Location
ALEXANDRIA, Va. – A large population-based study suggests that the utility of certain types of biomarkers, known as tumor-infiltrating lymphocytes (TILs), to predict colorectal cancer survival depends on where the tumor originates in the body. Read the full release.
- ASCO Photo Gallery
- Cancer.Net: Oncologist-approved patient information
- CancerProgress.Net: Interactive and downloadable charts and timelines and historical commentary on the progress against cancer